acc2301 |
RPS6 |
phosphorylation |
Ser235 |
human |
Breast Cancer |
SK-BR-3 |
Erlotinib + Pertuzumab |
Associated |
4.0 (Moderate) |
23552733
|
acc2302 |
RPS6 |
phosphorylation |
Ser236 |
human |
Breast Cancer |
SK-BR-3 |
Erlotinib + Pertuzumab |
Associated |
4.0 (Moderate) |
23552733
|
acc2303 |
IRAK1 |
phosphorylation |
unclear |
human |
Nasopharyngeal Carcinoma |
CNE2 R |
Paclitaxel |
Enhancing |
5.0 (High)
|
33402387
|
acc2304 |
IRAK1 |
phosphorylation |
unclear |
human |
Nasopharyngeal Carcinoma |
S26 R |
Paclitaxel |
Enhancing |
5.0 (High)
|
33402387
|
acc2305 |
NDRG-1 |
phosphorylation |
Thr346 |
human |
Myeloma |
BR bortezomib-resistant 8226 |
Bortezomib |
Impairing |
5.0 (High)
|
26869290
|
acc2306 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Colorectal Cancer |
HCT116 |
Celastrol derivative 4m |
Associated |
4.0 (Moderate) |
34894961
|
acc2307 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
A375 |
FLLL32 |
Associated |
4.0 (Moderate) |
20576164
|
acc2308 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
Hs294T |
FLLL32 |
Associated |
4.0 (Moderate) |
20576164
|
acc2309 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
DU145 |
Pimozide |
Associated |
4.0 (Moderate) |
26549437
|
acc2310 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Prostate Cancer |
LNCaP |
Pimozide |
Associated |
4.0 (Moderate) |
26549437
|
acc2311 |
Src |
phosphorylation |
Tyr416 |
human |
Lung Cancer |
FA31 |
Gefitinib |
Impairing |
5.0 (High)
|
19491201
|
acc2312 |
Src |
phosphorylation |
Tyr416 |
human |
Lung Cancer |
H1819 |
Gefitinib |
Impairing |
5.0 (High)
|
19491201
|
acc2313 |
Src |
phosphorylation |
Tyr416 |
human |
Lung Cancer |
H1975 |
Gefitinib |
Impairing |
5.0 (High)
|
19491201
|
acc2314 |
Neu |
phosphorylation |
Tyr1201 |
human |
Breast Cancer |
MCF7 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2315 |
Neu |
phosphorylation |
Tyr1226 |
human |
Breast Cancer |
MCF7 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2316 |
Neu |
phosphorylation |
Tyr1227 |
human |
Breast Cancer |
MCF7 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2317 |
Neu |
phosphorylation |
Tyr1201 |
human |
Breast Cancer |
T47D |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2318 |
Neu |
phosphorylation |
Tyr1226 |
human |
Breast Cancer |
T47D |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2319 |
Neu |
phosphorylation |
Tyr1227 |
human |
Breast Cancer |
T47D |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2320 |
Neu |
phosphorylation |
Tyr1201 |
mouse |
Breast Cancer |
4T1 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2321 |
Neu |
phosphorylation |
Tyr1226 |
mouse |
Breast Cancer |
4T1 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2322 |
Neu |
phosphorylation |
Tyr1227 |
mouse |
Breast Cancer |
4T1 |
Heregulin |
Associated |
4.0 (Moderate) |
19525980
|
acc2323 |
Smad2 |
phosphorylation |
Ser465 |
human |
Hepatocellular Carcinoma |
HepG2 |
NH4Cl |
Enhancing |
5.0 (High)
|
25342595
|
acc2324 |
Smad2 |
phosphorylation |
Ser467 |
human |
Hepatocellular Carcinoma |
HepG2 |
NH4Cl |
Enhancing |
5.0 (High)
|
25342595
|
acc2325 |
CtIP |
phosphorylation |
Thr847 |
human |
Ovarian Cancer |
IGROV1 |
Olaparib |
Impairing |
5.0 (High)
|
37333340
|
acc2326 |
CtIP |
phosphorylation |
Thr847 |
human |
Ovarian Cancer |
IGROV1 |
Cisplatin |
Impairing |
5.0 (High)
|
37333340
|
acc2327 |
Tau |
phosphorylation |
Thr205 |
human |
Neuroblastoma |
SH-SY5Y |
Ebselen |
Associated |
3.0 (Low)
|
22634399
|
acc2328 |
Tau |
phosphorylation |
Ser396 |
human |
Neuroblastoma |
SH-SY5Y |
Ebselen |
Associated |
3.0 (Low)
|
22634399
|
acc2329 |
Tau |
phosphorylation |
Thr231 |
human |
Neuroblastoma |
SH-SY5Y |
Ebselen |
Associated |
3.0 (Low)
|
22634399
|
acc2330 |
Smad2 |
phosphorylation |
Ser465 |
human |
Breast Cancer |
MCF7 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2331 |
Smad2 |
phosphorylation |
Ser467 |
human |
Breast Cancer |
MCF7 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2332 |
Smad3 |
phosphorylation |
Ser423 |
human |
Breast Cancer |
MCF7 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2333 |
Smad3 |
phosphorylation |
Ser425 |
human |
Breast Cancer |
MCF7 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2334 |
Smad2 |
phosphorylation |
Ser465 |
human |
Breast Cancer |
MDA-MB-231 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2335 |
Smad2 |
phosphorylation |
Ser467 |
human |
Breast Cancer |
MDA-MB-231 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2336 |
Smad3 |
phosphorylation |
Ser423 |
human |
Breast Cancer |
MDA-MB-231 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2337 |
Smad3 |
phosphorylation |
Ser425 |
human |
Breast Cancer |
MDA-MB-231 |
SSA |
Associated |
3.0 (Low)
|
26769851
|
acc2338 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
A375 |
Gentian violet |
Associated |
4.0 (Moderate) |
27373978
|
acc2339 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
SSM2c |
Gentian violet |
Associated |
4.0 (Moderate) |
27373978
|
acc2340 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Melanoma |
M33x |
Gentian violet |
Associated |
4.0 (Moderate) |
27373978
|
acc2341 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MCF7 |
Niclosamide |
Associated |
4.0 (Moderate) |
33002501
|
acc2342 |
STAT3 |
phosphorylation |
Ser727 |
human |
Breast Cancer |
MCF7 |
Niclosamide |
Associated |
4.0 (Moderate) |
33002501
|
acc2343 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Breast Cancer |
MCF7 |
Stattic |
Associated |
4.0 (Moderate) |
33002501
|
acc2344 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Myeloma |
ARH-77 |
LLL12 |
Associated |
4.0 (Moderate) |
21520044
|
acc2345 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Myeloma |
U266 |
Lenalidomide |
Impairing |
5.0 (High)
|
21520044
|
acc2346 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Myeloma |
MM1.S |
Lenalidomide |
Impairing |
5.0 (High)
|
21520044
|
acc2347 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
HepG2 |
XZH-5 |
Associated |
4.0 (Moderate) |
21311975
|
acc2348 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
HuH-7 |
XZH-5 |
Associated |
4.0 (Moderate) |
21311975
|
acc2349 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
SNU-387 |
XZH-5 |
Associated |
4.0 (Moderate) |
21311975
|
acc2350 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Hepatocellular Carcinoma |
SNU-398 |
XZH-5 |
Associated |
4.0 (Moderate) |
21311975
|